Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization

Yu Wang, Haihong Qin, Yuwen Gao, Zheng Li, Yuemeng Wu, Huibin Yin, Shangshang Wang, Xu Yao, Hao Wu, Chaoying Gu

Open source

DOI
10.1080/07853890.2026.2720965
Published
2026-08-24
Container
Annals of Medicine
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/07853890.2026.2720965,
  title = {Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization},
  author = {Yu Wang and Haihong Qin and Yuwen Gao and Zheng Li and Yuemeng Wu and Huibin Yin and Shangshang Wang and Xu Yao and Hao Wu and Chaoying Gu},
  year = {2026},
  journal = {Annals of Medicine},
  doi = {10.1080/07853890.2026.2720965},
  url = {https://doi.org/10.1080/07853890.2026.2720965}
}

RIS

TY  - JOUR
TI  - Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization
AU  - Yu Wang
AU  - Haihong Qin
AU  - Yuwen Gao
AU  - Zheng Li
AU  - Yuemeng Wu
AU  - Huibin Yin
AU  - Shangshang Wang
AU  - Xu Yao
AU  - Hao Wu
AU  - Chaoying Gu
PY  - 2026
JO  - Annals of Medicine
DO  - 10.1080/07853890.2026.2720965
UR  - https://doi.org/10.1080/07853890.2026.2720965
ER  - 

APA

Wang, Y., Qin, H., Gao, Y., Li, Z., Wu, Y., Yin, H., Wang, S., Yao, X., Wu, H., & Gu, C. (2026). Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization. Annals of Medicine. https://doi.org/10.1080/07853890.2026.2720965

Source records